We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-15.26%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$7.53B
AUM Growth
-$2.75B
Cap. Flow
-$1.08B
Cap. Flow %
-14.29%
Top 10 Hldgs %
12.34%
Holding
1,547
New
122
Increased
288
Reduced
505
Closed
182

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$67.4M
2
UNP icon
Union Pacific
UNP
+$58.9M
3
LLY icon
Eli Lilly
LLY
+$58.2M
4
MKC icon
McCormick & Company Non-Voting
MKC
+$55.5M
5
PLD icon
Prologis
PLD
+$44.7M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$86.6M
2
DINO icon
HF Sinclair
DINO
+$82.3M
3
CAT icon
Caterpillar
CAT
+$75.6M
4
FANG icon
Diamondback Energy
FANG
+$65.1M
5
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$59.8M

Sector Composition

Rank Sector Weight
1 Financials 24.04%
2 Healthcare 13.43%
3 Consumer Discretionary 11.21%
4 Industrials 10.14%
5 Technology 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFMS
1276
DELISTED
Conformis, Inc. Common Stock
CFMS
$124K ﹤0.01%
13,800
– –
TTPH
1277
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$124K ﹤0.01%
5,490
-3,750
-41% -$147K
CTHR
1278
DELISTED
Charles & Colvard Ltd
CTHR
$123K ﹤0.01%
14,430
– –
APVO icon
1279
Aptevo Therapeutics
APVO
$5.22M
– –
0
– –
GTIM icon
1280
Good Times Restaurants
GTIM
$15M
$118K ﹤0.01%
+47,300
New +$189K
REED
1281
DELISTED
Reeds, Inc. Common Stock
REED
$118K ﹤0.01%
1,144
– –
INSY
1282
DELISTED
Insys Therapeutics, Inc.
INSY
$118K ﹤0.01%
33,800
-50,900
-60% -$354K
MHH icon
1283
Mastech Digital
MHH
$94.4M
$117K ﹤0.01%
18,500
– –
APPS icon
1284
Digital Turbine
APPS
$1.59B
$116K ﹤0.01%
+63,600
New +$100K
KONA
1285
DELISTED
Kona Grill, Inc.
KONA
$116K ﹤0.01%
110,200
– –
CVM icon
1286
CEL-SCI Corp
CVM
$26.6M
$115K ﹤0.01%
1,333
– –
ALJJ
1287
DELISTED
ALJ Regional Holdings Inc
ALJJ
$115K ﹤0.01%
88,000
– –
AST
1288
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$115K ﹤0.01%
186,254
– –
BSQR
1289
DELISTED
BSQUARE Corporation
BSQR
$115K ﹤0.01%
74,500
– –
STRR
1290
Star Equity Holdings
STRR
$42.5M
$114K ﹤0.01%
8,440
– –
IMI
1291
DELISTED
Intermolecular, Inc.
IMI
$114K ﹤0.01%
113,100
-167,600
-60% -$168K
CSSE
1292
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$113K ﹤0.01%
15,000
– –
HZN
1293
DELISTED
Horizon Global Corporation
HZN
$113K ﹤0.01%
79,100
-10,700
-12% -$41.8K
KSPN
1294
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$111K ﹤0.01%
8,780
-500
-5% -$9.37K
XELB icon
1295
Xcel Brands
XELB
$6.54M
$108K ﹤0.01%
9,520
– –
PIR
1296
DELISTED
Pier 1 Imports, Inc.
PIR
$107K ﹤0.01%
17,475
-7,500
-30% -$205K
BRN icon
1297
Barnwell Industries
BRN
$14.3M
$106K ﹤0.01%
79,320
– –
CCLD icon
1298
CareCloud
CCLD
$108M
$106K ﹤0.01%
+28,000
New +$135K
IDN icon
1299
Intellicheck
IDN
$77.3M
$106K ﹤0.01%
49,700
– –
FRTX
1300
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$103K ﹤0.01%
278
– –
50 51
52
53 54

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bridgeway Capital Management held 1,547 positions worth $7.53B, down 27% from $10.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management withdrew a net $1.08B in Q4 2018, closing 182 positions and reducing 505 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Eli Lilly worth $60.3M.

  • Bridgeway Capital Management's largest Q4 2018 buy was Eli Lilly: 521,450 shares worth $60.3M.
  • Bridgeway Capital Management added most to Merck in Q4 2018, an estimated $67.4M increase.
  • Bridgeway Capital Management's biggest Q4 2018 reduction was ON Semiconductor, cutting an estimated $54.9M.
  • Bridgeway Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $86.6M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $7.53B portfolio in Q4 2018.
  • Bridgeway Capital Management opened 122 new positions and closed 182 in Q4 2018.
  • Bridgeway Capital Management's portfolio value fell 27% quarter-over-quarter to $7.53B.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.